Synthovial Seven

Executive Summary

Supplement marketer Hyalogic receives a May 5 FDA warning letter following an inspection last winter. Investigators collected labeling for Synthovial Seven stating "Hyaluronic acid (HA) has been proven by numerous medical studies to alleviate pain and suffering from arthritis of the knee and other joints" and "Patent approved for...arthritis and fibromyalgia." Although the product is labeled a dietary supplement, the claims render the product a drug, FDA states. Moreover, claims such as "more cushioning and lubricating properties for the joints" are not supported by scientific evidence. Edwardsville, Kansas-based firm says they are communicating with the agency and have hired a consultant to be sure they remain FDA compliant...